Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cellonis reports on use of stem cell therapy to treat child with diabetes

Aug. 25, 2010

FDA clears Prolor Biotech's IND for phase II trial of hGH-CTP

Aug. 25, 2010

MannKind provides Afrezza for Artificial Pancreas Project

Aug. 25, 2010

Synthetic calcium phosphate ceramics induce osteogenesis in preclinical study

Aug. 24, 2010

Nesina in combination with thiazolidinediones approved in Japan for diabetes

Aug. 24, 2010

Zydus-Cadila identifies new GPR119 receptor agonists

Aug. 24, 2010

Pfizer discloses new inhibitors of DGAT-1

Aug. 23, 2010

New DGAT-1 inhibitors claimed by Banyu Pharmaceutical

Aug. 23, 2010

Amsterdam Molecular Therapeutics provides update on Glybera MAA

Aug. 23, 2010

GCC-2680 shows promise as obesity therapeutic based on preclinical data

Aug. 23, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...